These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 38137398)

  • 1. The Role of Osteopontin in Atherosclerosis and Its Clinical Manifestations (Atherosclerotic Cardiovascular Diseases)-A Narrative Review.
    Kadoglou NPE; Khattab E; Velidakis N; Gkougkoudi E
    Biomedicines; 2023 Nov; 11(12):. PubMed ID: 38137398
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.
    Wolak T
    Atherosclerosis; 2014 Oct; 236(2):327-37. PubMed ID: 25128758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of osteopontin predict major adverse cardiovascular events in patients with severe carotid artery stenosis.
    Carbone F; Rigamonti F; Burger F; Roth A; Bertolotto M; Spinella G; Pane B; Palombo D; Pende A; Bonaventura A; Liberale L; Vecchié A; Dallegri F; Mach F; Montecucco F
    Int J Cardiol; 2018 Mar; 255():195-199. PubMed ID: 29317141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin: a multifunctional protein at the crossroads of inflammation, atherosclerosis, and vascular calcification.
    Cho HJ; Cho HJ; Kim HS
    Curr Atheroscler Rep; 2009 May; 11(3):206-13. PubMed ID: 19361352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum osteoprotegerin and osteopontin levels are associated with arterial stiffness and the presence and severity of coronary artery disease.
    Tousoulis D; Siasos G; Maniatis K; Oikonomou E; Kioufis S; Zaromitidou M; Paraskevopoulos T; Michalea S; Kollia C; Miliou A; Kokkou E; Papavassiliou AG; Stefanadis C
    Int J Cardiol; 2013 Sep; 167(5):1924-8. PubMed ID: 22640692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum osteopontin concentrations in relation to coronary artery disease.
    Mohamadpour AH; Abdolrahmani L; Mirzaei H; Sahebkar A; Moohebati M; Ghorbani M; Ferns GA; Ghayour-Mobarhan M
    Arch Med Res; 2015 Feb; 46(2):112-7. PubMed ID: 25743929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteopontin is synthesized by macrophage, smooth muscle, and endothelial cells in primary and restenotic human coronary atherosclerotic plaques.
    O'Brien ER; Garvin MR; Stewart DK; Hinohara T; Simpson JB; Schwartz SM; Giachelli CM
    Arterioscler Thromb; 1994 Oct; 14(10):1648-56. PubMed ID: 7918316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is serum Osteopontin a predictor of carotid atherosclerosis severity among prevalent hemodialysis patients?
    Behairy MA; Shawky S; Hamed R; Bawady S; Abdelsattar HA; Bichari W
    Clin Investig Arterioscler; 2022; 34(2):75-85. PubMed ID: 35144845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma osteopontin as a predictor of coronary artery disease: association with echocardiographic characteristics of atherosclerosis.
    Abdel-Azeez HA; Al-Zaky M
    J Clin Lab Anal; 2010; 24(3):201-6. PubMed ID: 20486203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin and osteoprotegerin in atherosclerotic plaque - are they significant markers of plaque vulnerability?
    Strobescu-Ciobanu C; Giuşcă SE; Căruntu ID; Amălinei C; Rusu A; Cojocaru E; Popa RF; Lupaşcu CD
    Rom J Morphol Embryol; 2020; 61(3):793-801. PubMed ID: 33817720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Osteopontin is elevated in patients with mitral annulus calcification independent from classic cardiovascular risk factors.
    Sponder M; Reuter C; Fritzer-Szekeres M; Litschauer B; Binder T; Strametz-Juranek J
    BMC Cardiovasc Disord; 2016 Jun; 16():132. PubMed ID: 27283399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma osteopontin levels are associated with the presence and extent of coronary artery disease.
    Ohmori R; Momiyama Y; Taniguchi H; Takahashi R; Kusuhara M; Nakamura H; Ohsuzu F
    Atherosclerosis; 2003 Oct; 170(2):333-7. PubMed ID: 14612215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin in Vascular Disease.
    Lok ZSY; Lyle AN
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):613-622. PubMed ID: 30727754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Complex Mechanisms and the Potential Effects of Statins on Vascular Calcification: A Narrative Review.
    Kadoglou NP; Stasinopoulou M; Velidakis N; Khattab E; Christodoulou E; Gkougkoudi E; Valsami G
    Rev Cardiovasc Med; 2024 Feb; 25(2):51. PubMed ID: 39077343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating osteopontin as a marker of early coronary vascular calcification in type two diabetes mellitus patients with known asymptomatic coronary artery disease.
    Berezin AE; Kremzer AA
    Atherosclerosis; 2013 Aug; 229(2):475-81. PubMed ID: 23880208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin-Targeted and PPARδ-Agonist-Loaded Nanoparticles Efficiently Reduce Atherosclerosis in Apolipoprotein E
    Huang X; Zhang Y; Zhang W; Qin C; Zhu Y; Fang Y; Wang Y; Tang C; Cao F
    ACS Omega; 2022 Aug; 7(33):28767-28778. PubMed ID: 36033674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibiting vascular smooth muscle cell proliferation mediated by osteopontin
    Shi X; Wu H; Liu Y; Huang H; Liu L; Yang Y; Jiang T; Zhou M; Dai M
    Front Pharmacol; 2022; 13():936677. PubMed ID: 36034838
    [No Abstract]   [Full Text] [Related]  

  • 18. Ultrasound/Optical Dual-Modality Imaging for Evaluation of Vulnerable Atherosclerotic Plaques with Osteopontin Targeted Nanoparticles.
    Li S; Gou T; Wang Q; Chen M; Chen Z; Xu M; Wang Y; Han D; Cao R; Liu J; Liang P; Dai Z; Cao F
    Macromol Biosci; 2020 Feb; 20(2):e1900279. PubMed ID: 31885210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of NPP1 is regulated during atheromatous plaque calcification.
    Nitschke Y; Hartmann S; Torsello G; Horstmann R; Seifarth H; Weissen-Plenz G; Rutsch F
    J Cell Mol Med; 2011 Feb; 15(2):220-31. PubMed ID: 20015201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oxidized low-density lipoprotein increases the proliferation and migration of human coronary artery smooth muscle cells through the upregulation of osteopontin.
    Liu J; Ren Y; Kang L; Zhang L
    Int J Mol Med; 2014 May; 33(5):1341-7. PubMed ID: 24590381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.